Purchase Order HT941025PE073
- Not listed
- The Defense Health Agency awarded a $239,102.79 firm fixed-price purchase order to Biomerieux Inc. (doing business as Vitek Systems, Inc.) on September 20, 2022, with an ultimate completion date of September 29, 2027. The contract covers the supply and maintenance of a VITEK 2XL microbiology analyzer system, including training, warranty, and consumables for the Walter Reed Army Institute of Research (WRAIR) in Silver Spring, Maryland. The place of performance is listed as Emigration Canyon,...
- The Defense Health Agency awarded Biomerieux Inc., operating as Vitek Systems, Inc., a firm fixed-price purchase order valued at $246,203.47 for VITEK Instrument Testing Reagents. The contract, awarded on October 1, 2021, with an ultimate completion date of September 30, 2026, will be performed at Fort Johnson South, Louisiana. This award represents a continuation of Biomerieux's role as a specialized sole-source provider of advanced microbiological diagnostic solutions to federal healthcare...
- Biomerieux Inc., operating as Vitek Systems, Inc., received a firm fixed-price purchase order valued at $1,465.56 for bacterial test kits from the Defense Medical Supply Chain on September 19, 2025, with an ultimate completion date of September 26, 2025. The award carries no set-aside designation, reflecting Biomerieux's status as a specialized provider of in vitro diagnostic solutions. Work will be performed in Emigration Canyon, Utah. Biomerieux is a global leader in microbiological testing...
- This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various...
- The U.S. Defense Health Agency (DHA) awarded a firm-fixed-price delivery order contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of a microbiology analyzer and consumables. The $87,980.77 contract has an ultimate completion date of December 16, 2022. Biomerieux Inc., through its Biomerieux, Inc. division, is the sole awardee and is not subject to any set-aside designations. The company is known for its proprietary diagnostic platforms, such as VITEK,...
- This contract was awarded by the Defense Health Agency, a defense agency, to Biomerieux Inc., a for-profit manufacturer of medical diagnostic equipment and reagents. The $17,658.76 firm fixed-price purchase order is for a full-service plan, with an ultimate completion date of April 1, 2023. The contract does not have a set-aside designation. Biomerieux Inc., through its Vitek Systems, Inc. division, has been awarded numerous federal contracts and Indefinite Delivery Vehicles (IDVs) by agencies...
- The U.S. Defense Health Agency awarded a firm-fixed-price purchase order contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of VITEK 2 reagents and consumables. The contract, valued at $98,916.95, has an ultimate completion date of September 30, 2026. This contract does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. Division, is a manufacturer of specialized medical diagnostic equipment, reagents, and supplies. The company has...
- This is a $25,138.84 firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Biomerieux Inc., doing business as Vitek Systems, Inc. The contract is for a BIOMERIEUX SERVICE AGREEMENT BASE YEAR and has an ultimate completion date of September 29, 2026. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in microbiological testing solutions for medical, food safety, and industrial applications. The company has been awarded numerous federal...
- The U.S. Defense Health Agency awarded a $103,972.90 firm-fixed-price contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of microbiology analyzers and reagents to support the Keesler Medical Center. The contract, which runs from October 1, 2023, to March 31, 2025, with two six-month option periods, covers microbial identification testing, antimicrobial susceptibility testing, and blood culture testing, along with the necessary equipment, consumables, and...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Biomerieux Inc., a global leader in in vitro diagnostics, for a BIOMERIEUX VITEK AND MYLA SERVICE CONTRACT. The contract has a ceiling value of $138,404.00 and an ultimate completion date of May 31, 2027. This award is not associated with any set-aside designation. The contract primarily involves the supply of Biomerieux's proprietary diagnostic platforms, such as VITEK, BioFire, and VIDAS systems,...
The Defense Health Agency awarded a $999,610.35 firm fixed-price purchase order to Biomerieux Inc. (doing business as Vitek Systems, Inc.) for maintenance and reagents on October 1, 2025, with an ultimate completion date of September 30, 2030. The contract, which carries no set-aside designation, will be performed in Emigration Canyon, Utah. As a global leader in in vitro diagnostics and microbiological testing solutions, Biomerieux provides specialized diagnostic platforms and related maintenance services to various federal healthcare agencies, including the Defense Health Agency, Department of Veterans Affairs, and Indian Health Service. This award represents a continuation of Biomerieux's established relationship with the Defense Health Agency and reflects the company's position as a primary provider of advanced diagnostic equipment maintenance and reagent supplies to federal healthcare systems. Biomerieux holds multiple indefinite delivery vehicles with various federal agencies, including blanket purchase agreements and indefinite delivery contracts with ceiling values ranging from $12,000 to $31.8 million, underscoring the company's role as a specialized diagnostic solutions provider across the federal government. The firm fixed-price structure ensures cost certainty for the government while the five-year performance period through 2030 provides sustained access to critical diagnostic maintenance and supply services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 9/25/25 |